Mast Therapeutics (MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.

September 13, 2016 11:51 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Mast Therapeutics (NYSE: MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Related Entities

Rodman & Renshaw

Add Your Comment